Trupanion, Inc. (NASDAQ:TRUP) Closed 10.8% Above Its 50 Day Average

0
100

Company shares are trading at $28.15 significantly higher than $25.41, the stock’s 50 day moving average and which is significantly above the 200 day moving average of $21.51. The 50 day moving average moved up $2.74 and the 200 day average was up $6.64. Trupanion, Inc. shares had a trading volume of 8,999 in the last trading session. Trading volume was down 95.73% under the stocks average daily volume.

Traders are more bearish on shares of the company looking at the motion in short interest. The company saw a rise in short interest of 3.01% as of the latest report on September 29, 2017. Short shares grew from 4,573,069 to 4,710,727 over that period. The days to cover decreased to 24.0 and the percentage of shorted shares is 0.16% as of September 29.

There has been some selling insider activity on Trupanion, Inc. (NASDAQ:TRUP) recently. President and CEO Darryl Rawlings sold 3,500 shares at an average price of $23.75 on September 20th. Rawlings now owns $34,342,619 of stock per an SEC filing yesterday.

Here are a few substantial investment firms who have updated their positions. Nine Ten Capital Management LLC grew its ownership by buying 217,487 shares an increase of 19.6%. Nine Ten Capital Management LLC controls 1,329,867 shares with a value of $29,762,000. The total value of its holdings increased 88.2%. As of the end of the quarter Cutler Group LP had disposed of 3,826 shares trimming its position 85.0%. The value of the company’s investment in Trupanion, Inc. increased from $11,000 to $17,000 increasing 54.5% since the last quarter.

As of quarter end Hamilton Lane Advisors LLC had bought a total of 28,574 shares growing its holdings by 83.9%. The value of the investment in TRUP went from $762,000 to $1,654,000 a change of $892,000 for the reporting period. Baillie Gifford & Co augmented its investment by buying 23,610 shares an increase of 27.0% in the quarter. Baillie Gifford & Co now holds 110,983 shares valued at $2,931,000. The value of the position overall is up by 49.9%.

August 2 investment analysts at Canaccord Genuity maintained a stock rating of “Buy” and moved up the price target from $10.00 to $29.00.

In the last earnings report the EPS was $-0.15 and is projected to be $-0.09 for the current year with 29,995,000 shares currently outstanding. Next quarter’s EPS is forecasted at $-0.01 and the next full year EPS is projected to be $0.03.

Trupanion, Inc., launched on April 4, 2006, provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers. The other business segment includes other operations that are not directly marketed to consumers..

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.